FDA Drug Recalls

Recalls / Class III

Class IIID-0167-2020

Product

Testosterone Cypionate Injection, USP, 2000 mg/10 mL, 1 mL Vial, Single-Dose, Rx only, Mfd. for: Wilshire Pharmaceuticals, Inc. Atlanta, GA 30328. NDC 52536-625-01

Brand name
Testosterone Cypionate
Generic name
Testosterone Cypionate
Active ingredient
Testosterone Cypionate
Route
Intramuscular
NDC
52536-625
FDA application
ANDA206368
Affected lot / code info
lot# 23803.002B, Exp 07/2020; 23803.005A, Exp 01/2021

Why it was recalled

Labeling:Label Mix-up: Shipper Carton labelled Testosterone Cypionate Injection, USP, 200mg/mL, 1 ml single-dose vials, found to contain shelf cartons labelled as Testosterone Cypionate Injection USP, 200mg/mL, 10 ml multi-dose vials which contain Testosterone Cypionate Injection USP, 200mg/mL,1mL single-does vials

Recalling firm

Firm
Arbor Pharmaceuticals Inc.
Manufacturer
Wilshire Pharmaceuticals
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
6 Concourse Pkwy Ste 1800, Atlanta, Georgia 30328-5353

Distribution

Quantity
67934 units
Distribution pattern
Nationwide in the US

Timeline

Recall initiated
2019-09-27
FDA classified
2019-10-30
Posted by FDA
2019-11-06
Terminated
2021-02-02
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0167-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: Testosterone Cypionate · FDA Drug Recalls